Lindbrook Capital’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | $557K | Buy |
7,574
+141
| +2% | +$10.4K | 0.05% | 209 |
|
2024
Q4 | $487K | Sell |
7,433
-456
| -6% | -$29.9K | 0.04% | 220 |
|
2024
Q3 | $615K | Sell |
7,889
-692
| -8% | -$53.9K | 0.05% | 195 |
|
2024
Q2 | $669K | Buy |
8,581
+576
| +7% | +$44.9K | 0.06% | 170 |
|
2024
Q1 | $542K | Buy |
8,005
+137
| +2% | +$9.28K | 0.05% | 206 |
|
2023
Q4 | $530K | Buy |
7,868
+652
| +9% | +$43.9K | 0.05% | 190 |
|
2023
Q3 | $489K | Sell |
7,216
-92
| -1% | -$6.23K | 0.05% | 184 |
|
2023
Q2 | $523K | Buy |
7,308
+98
| +1% | +$7.01K | 0.06% | 176 |
|
2023
Q1 | $500K | Buy |
7,210
+602
| +9% | +$41.8K | 0.06% | 172 |
|
2022
Q4 | $448K | Buy |
6,608
+280
| +4% | +$19K | 0.06% | 196 |
|
2022
Q3 | $347K | Buy |
6,328
+211
| +3% | +$11.6K | 0.06% | 192 |
|
2022
Q2 | $404K | Buy |
6,117
+970
| +19% | +$64.1K | 0.07% | 174 |
|
2022
Q1 | $341K | Buy |
5,147
+74
| +1% | +$4.9K | 0.05% | 206 |
|
2021
Q4 | $296K | Sell |
5,073
-28
| -0.5% | -$1.63K | 0.05% | 233 |
|
2021
Q3 | $306K | Buy |
5,101
+517
| +11% | +$31K | 0.08% | 103 |
|
2021
Q2 | $275K | Buy |
4,584
+132
| +3% | +$7.92K | 0.06% | 131 |
|
2021
Q1 | $221K | Buy |
4,452
+138
| +3% | +$6.85K | 0.05% | 142 |
|
2020
Q4 | $216K | Sell |
4,314
-112
| -3% | -$5.61K | 0.05% | 131 |
|
2020
Q3 | $243K | Buy |
4,426
+250
| +6% | +$13.7K | 0.07% | 110 |
|
2020
Q2 | $221K | Buy |
4,176
+494
| +13% | +$26.1K | 0.07% | 108 |
|
2020
Q1 | $164K | Sell |
3,682
-806
| -18% | -$35.9K | 0.06% | 119 |
|
2019
Q4 | $224K | Buy |
4,488
+96
| +2% | +$4.79K | 0.08% | 126 |
|
2019
Q3 | $196K | Sell |
4,392
-60
| -1% | -$2.68K | 0.07% | 137 |
|
2019
Q2 | $183K | Buy |
4,452
+191
| +4% | +$7.85K | 0.07% | 141 |
|
2019
Q1 | $172K | Sell |
4,261
-28
| -0.7% | -$1.13K | 0.07% | 142 |
|
2018
Q4 | $162K | Buy |
+4,289
| New | +$162K | 0.08% | 132 |
|